FRA:MRK - Merck KGaA Stock Price, Forecast & News

€90.68

-2.82 (-3.02 %)

(As of 03/29/2020 05:43 AM ET)

Add

Compare

Today's Range

€89.14

Now: €90.68▼

€92.28

50-Day Range

€83.46

MA: €108.07▼

€125.60

52-Week Range

€76.60

Now: €90.68▼

€115.00

Volume672,168 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Industry, Sector and Symbol

Stock Exchange FRA

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolFRA:MRK

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://www.merckgroup.com/

Phone+49-6151-720

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees51,039

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableOptionable

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

Merck KGaA (FRA:MRK) Frequently Asked Questions

How has Merck KGaA's stock been impacted by COVID-19 (Coronavirus)?

Merck KGaA's stock was trading at €98.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MRK stock has decreased by 8.1% and is now trading at €90.68. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Merck KGaA?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 2 sell ratings, 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Merck KGaA.

What price target have analysts set for MRK?

15 brokerages have issued 1-year price targets for Merck KGaA's shares. Their forecasts range from €94.00 to €128.00. On average, they anticipate Merck KGaA's stock price to reach €108.29 in the next twelve months. This suggests a possible upside of 19.4% from the stock's current price. View analysts' price targets for Merck KGaA.

Has Merck KGaA been receiving favorable news coverage?

Headlines about MRK stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Merck KGaA earned a news impact score of 1.2 on InfoTrie's scale. They also assigned press coverage about the healthcare company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutMerck KGaA.

Who are some of Merck KGaA's key competitors?

Some companies that are related to Merck KGaA include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).

What other stocks do shareholders of Merck KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include Micron Technology (MU), Cisco Systems (CSCO), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), QUALCOMM (QCOM), Boeing (BA), HDFC Bank (HDB), Netflix (NFLX), AbbVie (ABBV) and Abbott Laboratories (ABT).

Who are Merck KGaA's key executives?

Merck KGaA's management team includes the following people:

Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)
Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)
Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)
Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)
Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59)

What is Merck KGaA's stock symbol?

Merck KGaA trades on the FRA under the ticker symbol "MRK."

What is Merck KGaA's stock price today?

One share of MRK stock can currently be purchased for approximately €90.68.

What is Merck KGaA's official website?

The official website for Merck KGaA is http://www.merckgroup.com/.

How can I contact Merck KGaA?

Merck KGaA's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The healthcare company can be reached via phone at +49-6151-720.

MarketBeat Community Rating for Merck KGaA (FRA MRK)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		816 (Vote Outperform)
Underperform Votes:		940 (Vote Underperform)
Total Votes:		1,756

MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 3/29/2020 by MarketBeat.com Staff

Your Ultimate Investing Toolkit

Just $1.00 for your first month.